Establish self-regulatory body to maintain pharma products quality: Dr Mansukh Mandaviya urges industry
Minister said that the country is marching ahead in the field of research and innovation as the government has opened its research facilities to all including the private sector.
New Delhi: At the closing ceremony of IPA’s 8th Global Pharmaceutical Quality Summit, Union Minister for Chemicals & Fertilizers and Health & Family Welfare, Dr Mansukh Mandaviya said, “The Indian pharma industry should strive to maintain the reputation of India as the ‘Pharmacy of the World’ which was established during the Covid-19 crisis”
Addressing the gathering on the occasion, Shri. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, said, “The Indian pharmaceutical industry plays a critical role in shaping the health outcomes of patients globally. India is known for providing quality-assured affordable medicines worldwide. During the COVID-19 pandemic, the industry demonstrated resilience and is now known as the pharmacy of the world. Quality is the fundamental tenet of the pharmaceutical sector. Continuous investments in quality –systems, technology and talent – is fundamental as the overall healthcare landscape is evolving at an unprecedented pace. IPA is committed to making India a global benchmark in quality.”
The theme for the 8th edition of the Global Pharmaceutical Quality Summit was, ‘Patient Centricity: New Paradigm of Manufacturing and Quality’. The two-day Summit brought together industry leaders, global regulators, quality experts and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.
The event was inaugurated by Mr Samir Mehta, Chairman, Torrent Pharmaceuticals and President, IPA. Ms S Aparna, Secretary, Department of Pharmaceuticals, Government of India, delivered the keynote address during the inaugural session. The first day highlighted the importance of the future of manufacturing and building quality as a culture in the pharmaceutical industry. Regulators from around the world - US FDA, MHRA, EDQM and CDSCO discussed the regulatory affairs highlighting recent inspection observations and trends. The day concluded with discussions on technology architecture, exploring best-in-class engineering controls to ensure excellence in pharmaceutical production.
Day two of the summit witnessed industry leaders shedding light on industry advancements, continuous manufacturing, regulatory expectation, digital technologies in pharmaceutical manufacturing and learnings from other industries. The highlight of the day was the panel discussion comprising leading CEOs of the pharma industry from Cipla, Dr Reddy’s, Lupin, Sun Pharma and Zydus providing their thoughts on the future of the Indian pharmaceutical industry.
Read also: Dr Mansukh Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.